SCHEMBL29626809

SCHEMBL29626809

FC(F)(F)c1cc(N2CCCCC2)c2[nH]nc(Br)c2n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B10 Q99714 5/20 0.38
▸ MAPK1 P28482 4/20 0.38
▸ ALDH1A1 P00352 6/20 0.37
▸ KDM4E B2RXH2 6/20 0.37
▸ ADRB2 P07550 4/20 0.37
▸ TP53 P04637 1/20 0.37
▸ HPGD P15428 5/20 0.37
▸ TSHR P16473 2/20 0.37
▸ CASP1 P29466 1/20 0.37
▸ CASP7 P55210 1/20 0.37
▸ ADRA2A P08913 1/20 0.35
▸ HTR2C P28335 1/20 0.35
▸ AXL P30530 1/20 0.35
▸ HRH1 P35367 1/20 0.35
▸ HTR2B P41595 1/20 0.35
▸ HTR6 P50406 1/20 0.35
▸ MKNK1 Q9BUB5 1/20 0.35
▸ MKNK2 Q9HBH9 1/20 0.35
▸ NOTUM Q6P988 2/20 0.34
▸ CYP1A2 P05177 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31092008 0.85 HSP90AA1 (0.37) MAPK1ALDH1A1KDM4EADRB2HPGD
SCHEMBL28741889 0.74 NT5E (0.44) HSD17B10ALDH1A1KDM4EFABP4
SCHEMBL31091993 0.68 DHODH (0.34) CDK2
SCHEMBL3872027 0.66 ADRB2 (0.48) HSD17B10MAPK1ALDH1A1KDM4EADRB2
SCHEMBL3864885 0.61 MAPT (0.45) HSD17B10MAPK1ALDH1A1KDM4EADRB2
SCHEMBL28741778 0.61 GRM4 (0.33) —
SCHEMBL23599273 0.59 KMT2A (0.53) HSD17B10MAPK1ALDH1A1KDM4ETP53
SCHEMBL28437830 0.59 CRHBP (0.58) HSD17B10MAPK1ALDH1A1KDM4ETP53
SCHEMBL30545002 0.59 CRHBP (0.58) HSD17B10MAPK1ALDH1A1KDM4ETP53
SCHEMBL1285136 0.59 ADRB2 (0.53) HSD17B10MAPK1KDM4EADRB2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4003965-A1 UREA, AMIDE, AND SUBSTITUTED HETEROARYL COMPOUNDS FOR CBL-B INHIBITION Nurix Therapeutics, Inc. (US) 2022-06-01 — — EP disclosed
Send feedback